Casdin Partners GP, LLC 4
4 · GeneDx Holdings Corp. · Filed Aug 5, 2024
Insider Transaction Report
Form 4
Casdin Capital, LLC
Director10% Owner
Transactions
- Other
Class A Common Stock
2024-08-01$32.25/sh+413,655$13,340,374→ 3,507,164 total
Holdings
- 19,247(indirect: See footnote)
Class A Common Stock
- 333,144(indirect: See footnote)
Class A Common Stock
- 3,142
Class A Common Stock
Footnotes (5)
- [F1]Represents a cross-trade, pursuant to which Casdin Partners FO1-MSV, LP ("Casdin FO1") transferred 413,655 shares of Class A Common Stock to Casdin Partners Master Fund, L.P. (the "Master Fund"). No reporting person has any pecuniary interest in Casdin FO1.
- [F2]The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F3]The securities are owned directly by Eli Casdin.
- [F4]The securities are owned directly by the GP and may be deemed to be indirectly beneficially owned by Eli Casdin, the managing member of the GP.
- [F5]The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings.